CYPROTERONE: 784 Adverse Event Reports & Safety Profile
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
784
Total FAERS Reports
42 (5.4%)
Deaths Reported
296
Hospitalizations
784
As Primary/Secondary Suspect
47
Life-Threatening
75
Disabilities
Active Ingredient: CYPROTERONE ACETATE ·
First Report: 1982 · Latest Report: 20250701
What Are the Most Common CYPROTERONE Side Effects?
#1 Most Reported
Meningioma
378 reports (48.2%)
#2 Most Reported
Headache
116 reports (14.8%)
#3 Most Reported
Dementia alzheimer's type
96 reports (12.2%)
All CYPROTERONE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Meningioma | 378 | 48.2% | 6 | 168 |
| Headache | 116 | 14.8% | 0 | 90 |
| Dementia alzheimer's type | 96 | 12.2% | 0 | 0 |
| Off label use | 91 | 11.6% | 5 | 48 |
| Fatigue | 66 | 8.4% | 3 | 59 |
| Asthenia | 53 | 6.8% | 0 | 50 |
| Paraesthesia | 53 | 6.8% | 4 | 45 |
| Product use in unapproved indication | 51 | 6.5% | 7 | 19 |
| Dizziness | 48 | 6.1% | 0 | 34 |
| Visual impairment | 48 | 6.1% | 0 | 42 |
| Nausea | 43 | 5.5% | 2 | 35 |
| Pain | 40 | 5.1% | 3 | 36 |
| Depression | 37 | 4.7% | 3 | 31 |
| Cognitive disorder | 34 | 4.3% | 1 | 33 |
| Migraine | 34 | 4.3% | 0 | 34 |
| Memory impairment | 33 | 4.2% | 2 | 29 |
| Balance disorder | 32 | 4.1% | 1 | 31 |
| Epilepsy | 32 | 4.1% | 1 | 29 |
| Arthralgia | 30 | 3.8% | 0 | 29 |
| Diplopia | 30 | 3.8% | 1 | 22 |
Who Reports CYPROTERONE Side Effects? Age & Gender Data
Gender: 75.7% female, 24.3% male. Average age: 46.9 years. Most reports from: FR. View detailed demographics →
Is CYPROTERONE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 4 | 0 | 4 |
| 2002 | 11 | 0 | 10 |
| 2004 | 5 | 0 | 4 |
| 2005 | 9 | 1 | 6 |
| 2007 | 7 | 0 | 7 |
| 2008 | 6 | 0 | 4 |
| 2009 | 4 | 0 | 3 |
| 2010 | 7 | 2 | 2 |
| 2011 | 5 | 1 | 1 |
| 2012 | 7 | 2 | 4 |
| 2013 | 25 | 0 | 16 |
| 2014 | 25 | 0 | 21 |
| 2015 | 36 | 0 | 26 |
| 2016 | 32 | 0 | 10 |
| 2017 | 54 | 5 | 34 |
| 2018 | 43 | 3 | 30 |
| 2019 | 89 | 10 | 15 |
| 2020 | 16 | 0 | 1 |
| 2021 | 12 | 0 | 2 |
| 2022 | 5 | 0 | 1 |
| 2023 | 18 | 1 | 6 |
| 2024 | 5 | 0 | 0 |
| 2025 | 3 | 0 | 3 |
What Is CYPROTERONE Used For?
| Indication | Reports |
|---|---|
| Prostate cancer | 164 |
| Product used for unknown indication | 113 |
| Transgender hormonal therapy | 85 |
| Hirsutism | 64 |
| Hyperandrogenism | 29 |
| Acne | 27 |
| Antiandrogen therapy | 22 |
| Paraphilia | 22 |
| Androgenetic alopecia | 21 |
| Alopecia | 19 |
CYPROTERONE vs Alternatives: Which Is Safer?
CYPROTERONE vs CYPROTERONE\ETHINYL ESTRADIOL
CYPROTERONE vs CYSTEAMINE
CYPROTERONE vs CYTARABINE
CYPROTERONE vs CYTARABINE\DAUNORUBICIN
CYPROTERONE vs DABIGATRAN
CYPROTERONE vs DABIGATRAN ETEXILATE
CYPROTERONE vs DABRAFENIB
CYPROTERONE vs DABRAFENIB\TRAMETINIB
CYPROTERONE vs DACARBAZINE
CYPROTERONE vs DACLATASVIR
Official FDA Label for CYPROTERONE
Official prescribing information from the FDA-approved drug label.